Activase - activase.com : Activase® (Alteplase) for Acute Ischemic Stroke Treatment

2.33 Rating by ClearWebStats

activase.com is 2 decades 5 years 3 weeks old. This website has a #52,023 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 4 out of 10. This domain is estimated value of $ 159,840.00 and has a daily earning of $ 222.00. It is also listed in Dmoz. While no active threats were reported recently by users, activase.com is SAFE to browse.

Updated 9 years 5 months ago

Get Custom Widget

Traffic Report of Activase

Daily Unique Visitors:	18,496
Daily Pageviews:	110,976

Estimated Valuation

Income Per Day:	$ 222.00
Estimated Worth:	$ 159,840.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	2,382

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Not Applicable
WOT Privacy:	Not Applicable
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	52,023
Domain Authority:	Not Applicable

Google Pagerank

PR 4 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is activase.com server located?

Hosted IP Address:

72.34.128.168

View other site hosted with activase.com

Hosted Country:

Location Latitude:

45.4207

Location Longitude:

-122.671

Social Engagement

Facebook Shares:	Not Applicable
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View activase.com homepage link analysis

Page Title of Activase

Activase® (Alteplase) for Acute Ischemic Stroke Treatment

Meta Description of Activase

Acute Ischemic Stroke Indication: Activase is indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability. Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography (CT) scan or other diagnostic imaging method sensitive for the presence of hemorrhage (see CONTRAINDICATIONS in the full prescribing information). Acute Massive Pulmonary Embolism Indication: Activase is indicated in the management of acute massive pulmonary embolism (AMPE) in adults: (1) for the lysis of acute pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments of the lungs; (2) for the lysis of pulmonary emboli accompanied by unstable hemodynamics, eg, failure to maintain blood pressure without supportive measures. The diagnosis should be confirmed by objective means, such as pulmonary angiography or noninvasive procedures such as lung scanning. Acute Mycocardial Infarction Indication: Activase (alteplase) is indicated for use in the management of acute myocardial infarction in adults for the improvement of ventricular function following AMI, the reduction of the incidence of congestive heart failure, and the reduction of mortality associated with AMI. Treatment should be initiated as soon as possible after the onset of AMI symptoms. Important Safety Information: CONTRAINDICATIONS Acute Ischemic Stroke (AIS): Treatment should only be initiated within 3 hours after the onset of stroke symptoms, and after exclusion of intracranial hemorrhage by a cranial computerized tomography (CT) scan or other diagnostic imaging method sensitive for the presence of hemorrhage [See CONTRAINDICATIONS in the full prescribing information]. Activase therapy in patients with AIS is contraindicated in certain situations (eg, suspicion of subarachnoid hemorrhage on pretreatment evaluation), recent (within 3 months) intracranial or intraspinal surgery, history of intracranial hemorrhage, uncontrolled hypertension at time of treatment, active internal bleeding, known bleeding diathesis (eg, current use of oral anticoagulants, administration of heparin within 48 hours of onset of stroke, platelet count 22) at presentation. There is an increased risk of intracranial hemorrhage in these patients. Patients with major early infarct signs on a computerized cranial tomography (CT) scan (eg, substantial edema, mass effect, or midline shift). Treatment of patients with minor neurological deficit or with rapidly improving symptoms is not recommended [See WARNINGS in the full prescribing information]. Pulmonary Embolism (PE): Treatment of PE with Activase has not been shown to constitute adequate clinical treatment of underlying deep vein thrombosis. The possible risk of reembolization due to the lysis of underlying deep venous thrombi should be considered. Acute Myococardial Infarction (AMI): Coronary thrombolysis may result in arrhythmias associated with reperfusion. It is recommended that antiarrhythmic therapy for bradycardia and/or ventricular irritability be available when infusions of Activase are administered. PRECAUTIONS (AIS) Orolingual angioedema has been observed in postmarketing experience in patients treated with Activase for AIS. Patients should be monitored during and for several hours after infusion for signs of orolingual angioedema. ADVERSE REACTIONS The most common complication during Activase therapy is bleeding. Should serious bleeding in a critical location (intracranial, gastrointestinal, retroperitoneal, pericardial) occur, Activase therapy should be discontinued immediately, along with any concomitant therapy with heparin. Death and permanent disability are not uncommonly reported in patients who have experienced stroke (including intracranial bleeding) and other serious bleeding episodes. Please see www.Activase.com for full Prescribing Information for additional Important Safety Information. Activase® (Alteplase) is the only FDA-approved drug for the treatment of acute ischemic stroke.

Meta Tags of Activase

acute ischemic stroke, acute ischemic stroke treatment, activase alteplase, activase stroke treatment, activase

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	2
H3 Headings:	15	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	1	Total Images:	6
Google Adsense:	Not Applicable	Google Analytics:	UA-6467920-1

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Tue, 02 Dec 2014 17:51:09 GMT
X-Powered-By: Servlet 2.5; JBoss-5.0/JBossWeb-2.1
Content-Disposition: inline;filename="index.html"
Accept-Ranges: bytes
ETag: /_1415748536946
Last-Modified: Tue, 11 Nov 2014 23:28:56 GMT
Content-Range: bytes 0-75507/75507
Content-Length: 75507
Keep-Alive: timeout=1, max=95
Connection: close
Content-Type: text/html;charset=UTF-8
Content-Language: en

Domain Information for activase.com

Domain Registrar:	CSC CORPORATE DOMAINS, INC.
Registration Date:	1999-04-23 2 decades 5 years 3 weeks ago
Last Modified:	2014-04-19 1 decade 4 weeks 13 hours ago
Expiration Date:	2015-04-23 9 years 3 weeks 2 days ago

Domain Nameserver Information

Host	IP Address	Country
dnadns2e.gene.com	72.34.128.76	United States
dnadns3e.gene.com	72.34.133.50	United States
dnadns4e.gene.com	72.34.128.50	United States

DNS Record Analysis

Host	Type	TTL	Extra
activase.com	A	429	IP:72.34.128.168
activase.com	NS	3599	Target:dnadns4e.gene.com
activase.com	NS	3599	Target:dnadns3e.gene.com
activase.com	NS	3599	Target:dnadns2e.gene.com
activase.com	SOA	3599	MNAME:bc-dns-ext-mstr.gene.com RNAME:postmaster.no.email.please Serial:404592124 Refresh:3600 Retry:600 Expire:2592000
activase.com	MX	3599	Priority:10 Target:smtaextrwc01.gene.com
activase.com	MX	3599	Priority:10 Target:smtaextrwc02.gene.com
activase.com	MX	3599	Priority:10 Target:smtaextvv01.gene.com
activase.com	MX	3599	Priority:10 Target:smtaextvv02.gene.com

Similarly Ranked Websites to Activase

Dragon Cave - Enter the Cave

- dragcave.net

52,024

$ 159,840.00

American Battlefield Trust

- battlefields.org

The American Battlefield Trust is a charitable organization whose primary focus is the preservation of battlefields of the American Civil War, the Revolutionary War and the War of 1812 through acquisition of battlefield land. The American Battlefield Trust is the umbrella organization for two divisions -- the Civil War Trust and the Revolutionary War Trust.

52,024

$ 159,840.00

Email Marketing

- e-goi.com.br

Criar e enviar campanhas de email marketing, SMS Marketing. Programa para envio de email marketing.

52,025

$ 159,840.00

Allotment Growing: Vegetable, Fruit and Herb Gardening on an Allotment

- allotment.org.uk

Allotment Growing, help and advice on finding and growing on an allotment, vegetable and herb gardening - includes allotment diary, help, information and the allotment forums. New to allotments or just want an allotment, this is the place to come.

52,026

$ 159,840.00

Rafapal Periodismo para Mentes Galacticas

- rafapal.com

52,026

$ 159,840.00

Web stats for Activase - activase.com

Traffic Report of Activase

Estimated Valuation

Search Engine Indexes

Search Engine Backlinks

Safety Information

Website Ranks & Scores

PageSpeed Score

Siteadvisor Rating

Where is activase.com server located?

Social Engagement

Page Resources Breakdown

Homepage Links Analysis

Website Inpage Analysis

HTTP Header Analysis

Domain Information for activase.com

Domain Nameserver Information

DNS Record Analysis

Similarly Ranked Websites to Activase

Dragon Cave - Enter the Cave

American Battlefield Trust

Email Marketing

Allotment Growing: Vegetable, Fruit and Herb Gardening on an Allotment

Rafapal Periodismo para Mentes Galacticas